Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

More News

21 Savage donates $25K for legal aid for detained immigrants

Jun 15, 2019

ATLANTA — Grammy-nominated rapper 21 Savage has given $25,000 to the Southern Poverty Law Center after the watchdog organization helped him while he was in federal immigration custody earlier this year. The rapper, whose real name is She'yaa Bin Abraham-Joseph, was arrested Feb. 3 in what U.S. Immigration and Customs Enforcement has said was a targeted operation over his expired visa. Abraham-Joseph is a British citizen and moved to the U.S. when he was 7. In a statement, immigration attorney Charles Kuck said that the Atlanta-based rapper wants to support the work the SPLC has done to give immigrants legal...

Publisher delays US release of Naomi Wolf book 'Outrages'

Jun 15, 2019

NEW YORK — Naomi Wolf's U.S. publisher is postponing the release of her new book, "Outrages," after a BBC interviewer challenged some of her findings. Wolf is openly objecting to the delay. Houghton Mifflin Harcourt announced that "new questions" had come up about "Outrages," originally scheduled to come out next week. It has already been published in the United Kingdom. "As we have been working with Naomi Wolf to make corrections to 'Outrages,' new questions have arisen that require more time to explore, according to a statement from the publisher. "We are postponing publication and requesting that all copies be...

Broncos owner Pat Bowlen dies at 75 before Hall enshrinement

Jun 15, 2019

ENGLEWOOD, Colo. — On a cool night in Santa Clara, California, on Feb. 7, 2016, John Elway thrust the Lombardi Trophy into the air and hollered, "This one's for Pat!" It came 18 years after Denver Broncos owner Pat Bowlen had declared, "This one's for John!" following the franchise's first Super Bowl championship, a 31-24 win over Green Bay in San Diego after Elway helicoptered his way into NFL immortality in his fourth shot at a title. Elway called it the greatest moment of his Hall of Fame career, and he was determined to return the favor after rejoining his...

Julio Iglesias reflects on a life that 'has been a miracle'

Jun 15, 2019

NEW YORK — At 75 and after a five-decade-long career, Julio Iglesias keeps performing internationally, driven by his passion and, above all, a relentless discipline. It's something the Spanish crooner says he had to learn early on, after a nearly fatal car accident frustrated his plans to play professional soccer. "In fact, my life has been a miracle," says Iglesias, recalling how he spent "months and months" in bed unable to move, and then needed canes to walk for more than two years. The "magical" accident — as he calls it today — stripped him of his physical strength and...

Missy Elliott, in tears, gets inducted into Songwriters Hall

Jun 15, 2019

NEW YORK — Missy Elliott, the creative mastermind who has written hit songs for a number of female acts and created camaraderie among women in the music industry for more than two decades, felt the love back from her musical sisters as she became the first female rapper inducted into the Songwriters Hall of Fame. During a performance, breakthrough singer-rapper Lizzo brought Elliott's colorful and eccentric music videos to life in an ensemble similar to what Elliott sported in the late '90s — the finger wave hairdo included. Da Brat, fiery as ever, joined Lizzo onstage for "Sock It 2...

In Celeb Wired, we talk about everything in the entertainment industry from A to Z. We keep our gossip hunters updated with the daily hot news because we have exactly what you’re looking for.

Contact us: sales@celebwired.com

Celebrity Adult Entertainment Animation & Comics Award Shows Beauty Pageants Books & Literature Fashion Shows Movies Music Radio Programs Television Programs Variety Shows Press Releases